CB
Cadenza Bio, Inc.
SEC filingBiotechnology · Yukon, OK
Amount raised$2.4Msold at filing
Total offering$2.4M
Investors in the raise10count reported to the SEC
FiledAug 28, 2025first sale Dec 4, 2023
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Elaine HammExecutive Officer, Director
Tom DenisonDirector
Carol CurtisExecutive Officer, Director
Executive officers, directors and promoters as listed on the Form D.